Advanced search×

In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds.

Margarita M Garau, Manolo M Pereiro, and Amalia A del Palacio

Antimicrob Agents Chemother 47(7):2342-4 (2003) PMID 12821494 PMCID 161882

The in vitro activity of the new triazole albaconazole (UR-9825) in comparison with those of flucytosine, fluconazole, ketoconazole, itraconazole, and voriconazole against 70 strains of Malassezia spp. was determined by a microdilution method using a colorimetric indicator for metabolic activity. Albaconazole showed an in vitro profile similar to those of the different antifungals tested (MIC <or= 0.06 microg/ml for all the strains).

DOI: 10.1128/AAC.47.7.2342-2344.2003
Version: za2963e q8zac q8zb6 q8zc3 q8zd9 q8ze2 q8zf6 q8zg0

Similar articles you may find interesting…

  1. Treatment of Acute Antibody-Mediated Rejection: A Single-Center Experience
    M M Rodríguez Ferrero, A A Rincón, ... F F Anaya

    Transplant Proc 42(8):3 (2010) PMID 20970547

    Early diagnosis and treatment with PP, IVIG, and RTX may resolve AMR. PP before and after transplantation in high-risk patients may result in anti-HLA class I and class II antibody removal from plasma and prevention of AMR. Copyright © 2010 Elsevier Inc. All rights reserved....
  2. Early statin use is an independent predictor of long-term graft survival.
    Francesc Moreso, Natividad Calvo, ... Daniel Serón

    NDT Plus 3(Suppl_2):ii26-ii31 (2010) PMID 20508861

  3. Acute antibody-mediated rejection after ABO-incompatible kidney transplantation treated successfully with antigen-specific immunoadsorption.
    Søren Andreas Just, Niels Marcussen, ... Claus Bistrup

    Nephrol Dial Transplant 25(1):310 (2010) PMID 19820002

    We report on the first patient treated with this protocol who developed acute antibody-mediated rejection (Banff grade II with IgG deposits) caused by ABO antibodies (anti-B). Anti-rejection treatment with anti-B-specific immunoadsorption, intravenous immunoglobulin and methylprednisolone efficientl...